Добірка наукової літератури з теми "Hepatitis A Vaccination"
Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями
Ознайомтеся зі списками актуальних статей, книг, дисертацій, тез та інших наукових джерел на тему "Hepatitis A Vaccination".
Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.
Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.
Статті в журналах з теми "Hepatitis A Vaccination"
Arnold, Jana Nele, Nils Gundlach, Irina Böckelmann, and Stefan Sammito. "Impfstatus von jungen Arbeitnehmern – Eine Erhebung bei Berufsanfängern der Bundeswehr." ASU Arbeitsmedizin Sozialmedizin Umweltmedizin 2020, no. 12 (November 27, 2020): 770–75. http://dx.doi.org/10.17147/asu-2012-8715.
Повний текст джерелаCassimos, Dimitrios C., Evgnosia Effraimidou, Snezana Medic, Theoharis Konstantinidis, Maria Theodoridou, and Helena C. Maltezou. "Vaccination Programs for Adults in Europe, 2019." Vaccines 8, no. 1 (January 20, 2020): 34. http://dx.doi.org/10.3390/vaccines8010034.
Повний текст джерелаLee, Jin Young, Ji Young Park, Young Hee Lee, Je Hun Kim, and Jong Woo Park. "Changes in the vaccination rate among healthcare workers in response to hospital policies." Journal of Infection in Developing Countries 12, no. 04 (April 30, 2018): 250–56. http://dx.doi.org/10.3855/jidc.9940.
Повний текст джерелаVarughese, Tilly, Michael Song, and Joachim Sackey. "1379. Vaccination Rates among Liver Transplant Recipients at a Tertiary Care Hospital in Newark, NJ." Open Forum Infectious Diseases 8, Supplement_1 (November 1, 2021): S775—S776. http://dx.doi.org/10.1093/ofid/ofab466.1571.
Повний текст джерелаDsouza, Nikhil, and Manjunath Jeevanna Kulkarni. "Evaluating the efficacy of the hepatitis B vaccination in haemodialysis patients." Journal of Kidney Care 7, no. 6 (November 2, 2022): 279–81. http://dx.doi.org/10.12968/jokc.2022.7.6.279.
Повний текст джерелаGuo, Na, Jian Wang, Stephen Nicholas, Elizabeth Maitland, and Dawei Zhu. "Behavioral Differences in the Preference for Hepatitis B Virus Vaccination: A Discrete Choice Experiment." Vaccines 8, no. 3 (September 14, 2020): 527. http://dx.doi.org/10.3390/vaccines8030527.
Повний текст джерелаMaltezou, Helena C., Christos Rahiotis, Maria Tseroni, Phoebus Madianos, and Ioannis Tzoutzas. "Attitudes toward Vaccinations and Vaccination Coverage Rates among Dental Students in Greece." International Journal of Environmental Research and Public Health 19, no. 5 (March 1, 2022): 2879. http://dx.doi.org/10.3390/ijerph19052879.
Повний текст джерелаMikhailov, M. I., and K. K. Kyuregyan. "Contemporary strategy to control viral hepatitis A in the Russian Federation." Journal of microbiology, epidemiology and immunobiology 98, no. 2 (May 5, 2021): 190–97. http://dx.doi.org/10.36233/0372-9311-103.
Повний текст джерелаKuznetsova, O. A., A. A. Golubkova, and N. V. Bashmakova. "Modern Practices of Vaccination of Children from Perinatal Risk Groups and Necessary Precaution." Epidemiology and Vaccinal Prevention 19, no. 5 (November 11, 2020): 98–103. http://dx.doi.org/10.31631/2073-3046-2020-19-5-98-103.
Повний текст джерелаAbdel-Rahman, Omar. "Patterns and association of vaccination among adults with a history of cancer in the USA: a population-based study." Journal of Comparative Effectiveness Research 10, no. 11 (August 2021): 899–907. http://dx.doi.org/10.2217/cer-2020-0251.
Повний текст джерелаДисертації з теми "Hepatitis A Vaccination"
Sharma, Aditya. "Cost-effectiveness of Hepatitis A and Hepatitis B Vaccination for Jail Inmates." Yale University, 2008. http://ymtdl.med.yale.edu/theses/available/etd-08272007-114829/.
Повний текст джерелаDannetun, Eva. "Reasons for non-vaccination /." Stockholm, 2006. http://diss.kib.ki.se/2006/91-7140-739-1/.
Повний текст джерелаZhu, Sheng, and 朱晟. "Effect of the health belief model in explaining HBV screening and vaccination health behaviour : a systematic review." Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2013. http://hdl.handle.net/10722/193831.
Повний текст джерелаpublished_or_final_version
Public Health
Master
Master of Public Health
Karthigesu, Vassandra Devi. "A study of hepatitis B virus variation and antigenic variants." Thesis, Royal Veterinary College (University of London), 1996. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.309416.
Повний текст джерелаRadix, Jane. "Hepatitis B vaccination as a component of routine adult care." Thesis, Teachers College, Columbia University, 2014. http://pqdtopen.proquest.com/#viewpdf?dispub=3621790.
Повний текст джерелаThough hepatitis B virus infection is vaccine preventable, it remains a leading cause of serious liver disease including cirrhosis and hepatocellular carcinoma. With more than 2 million individuals living in the United States chronically infected, increasing the adult vaccination rate, currently estimated at only 26.3% based on large patient self-report surveys, is a public health imperative. Primary care visits represent an opportunity to assess hepatitis B risk and vaccination status, and to administer vaccine.
The purpose of the study was to determine the factors that affect primary care physician recommendation and delivery of hepatitis B vaccine as part of routine adult care, and measure vaccination rate in the primary care setting. A survey was developed, validated and completed online by a random sample of 319 physicians who provide routine primary care for >100 adult patients each month. Adult hepatitis B vaccination rate was calculated based on physician-reported caseload and number of vaccinations administered over a 6 month period. In addition to practice descriptors, 24 survey items assessed physician knowledge, attitudes and practices related to vaccination rate.
Statistical analyses were conducted using SPSS software. The median and mean vaccination rates were 3.3% and 9.4%, respectively. Vaccination rates were highest among physicians practicing medicine for <10 years, in private hospital settings located in urban areas. Vaccination significantly correlated (p<.05) with routine assessment of hepatitis B risk, guidelines-based vaccination, and distribution of patient education materials. Focusing on history of intravenous drug use as the key indication for vaccination and concerns regarding related liability were found to be barriers to vaccination. Forward multiple linear regression analysis generated a model that predicted 26% of variance in vaccination rate, which suggested that physicians who have integrated risk assessment, discussion of vaccination rationale with patients, and vaccine delivery into their routine primary care practices exhibit higher vaccination rates.
The results suggest that adult hepatitis B vaccination rates may be increased through physician education that reinforces identification of CHB risk factors other than intravenous drug use and clarifies the limited nature of vaccine injury liability, as well as health policies that incentivize vaccination in the primary care setting.
Baars, J. E. "Hard to reach? Hepatitis B vaccination among high-risk groups." [S.l.] : [The Author], 2009. http://hdl.handle.net/1765/14434.
Повний текст джерелаOhlson, Emilia, and Frida Bladh. "Knowledge about hepatitis B and attitudes towards hepatitis B vaccination among university students in Thailand : A quantitative study." Thesis, Uppsala universitet, Institutionen för folkhälso- och vårdvetenskap, 2015. http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-272494.
Повний текст джерелаSiriyasatien, Padet. "An assessment of hepatitis B vaccine delivery by transgenic Aedes aegypti mosquitoes." Thesis, University of Liverpool, 2000. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.367187.
Повний текст джерелаLu, Qiuying Sandy, and 呂秋瑩. "Health economic evaluation of universal infant hepatitis B vaccination programmes in China." Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2014. http://hdl.handle.net/10722/207183.
Повний текст джерелаpublished_or_final_version
Public Health
Doctoral
Doctor of Philosophy
Mureithi, John Gachagua. "Hepatitis B vaccination policies and coverage for nurse working at public and private hospitals in Tshwane, South Africa." Thesis, University of Limpopo (Medunsa Campus), 2009. http://hdl.handle.net/10386/248.
Повний текст джерелаBACKGROUND AND AIM: Hepatitis B virus (HBV) is the major cause of hepatitis in South Africa (SA), with an estimated 4 million carriers. It is transmitted by infected blood and other body fluids, placing health care workers (HCWs) at high risk of infection. The SA Department of Health strongly recommends that all HCWs be vaccinated against HBV, but studies have shown that uptake of the vaccine is sub-optimal. This study aimed to estimate HB vaccination coverage levels among nurses, and describe the demographics and characteristics of the HB vaccination policies associated with different levels of coverage, at private and public hospitals in Tshwane. METHODS: This was a questionnaire-based cross-sectional study on 300 randomly selected nurses and 12 chief infection control officers (CICOs) from 13 hospitals (6 public and 7 private) in Tshwane performing high risk procedures. CICOs were asked questions about HB vaccination policies and coverage, while nurses were asked about demographics, HB vaccination status, and the HB vaccination policies of their institutions. RESULTS: The response rate was 84.3% (253/300) for nurses, and 75% (9/12) for CICOs. Of the nurses, 68.0% (172/253) were vaccinated, and logistic regression analysis found that those statistically significantly most likely to be vaccinated were: 30 years and younger (odds ratio [OR]=2.9; 95% CI: 1.11–7.59); employed in private hospitals (OR=3.0; 95% CI: 1.24–7.32); and graduated after 1990 (OR=2.6; 95% CI: 1.10–6.19). Also, logistic regression analysis found two statistically significant policy-related predictor for vaccination uptake, which was the presence of HB vaccination program (OR=4.6; 95% CI: 2.11-10.06); and compulsory HB vaccination (OR=2.8; 95% CI: 1.37-5.70. CONCLUSION: There is a need for a national policy on HB vaccination of HCWs which should include compulsory vaccination, to increase the vaccination coverage level amongst nurses.
Книги з теми "Hepatitis A Vaccination"
Damme, Pierre van. Hepatitis B: Epidemiology and evaluation of vaccination. Antwerpen: University of Antwerp Press, Centre for Evaluation of Vaccination, Epidemiology and Community Medicine, 1994.
Знайти повний текст джерелаSymposium in Immunology (7th 1997?). Symposium in Immunology VII: Vaccination. Berlin: Springer, 1998.
Знайти повний текст джерелаCenters for Disease Control (U.S.), ed. Hepatitis B prevention and pregnancy: How to protect your baby against hepatitis B. Atlanta, Ga: Hepatitis Branch, Division of Viral and Rickettsial Diseases, National Center for Infectious Diseases, Centers for Disease Control, 1994.
Знайти повний текст джерелаWorkshop on Hepatitis B Immunization in the South Pacific (1989 Suva, Fiji). Report. Manila, Philippines: The Office, 1989.
Знайти повний текст джерелаEdwards, Vivien. Battling the big B: Hepatitis B in New Zealand. Wellington [N.Z.]: Dunmore Publishing, 2006.
Знайти повний текст джерелаHonig, Robert E. A review of public and private programs that test for the human immunodeficiency virus (HIV) and the hepatitis B virus (HBV): And issues related to vaccination programs for bloodborne diseases. [Washington, D.C.]: Dept. of Labor, 1989.
Знайти повний текст джерелаUnited States. Congress. House. Committee on Government Reform. Subcommittee on Criminal Justice, Drug Policy, and Human Resources. Hepatitis B vaccine: Helping or hurting public health? : hearing before the Subcommittee on Criminal Justice, Drug Policy, and Human Resources of the Committee on Government Reform, House of Representatives, One Hundred Sixth Congress, first session, May 18, 1999. Washington: U.S. G.P.O., 2000.
Знайти повний текст джерелаOon, Gabriel Chong Jin. A cancer vaccine that transformed Singapore and the world: The battle against Hepatitis B. Singapore: Straits Times Press Reference, 2011.
Знайти повний текст джерелаMadhavi, Y. Liberalisation and its impact on the cost-benefit aspects of vaccines: The case of Hepatitis B. Mumbai: Tata Institute of Social Sciences, 2001.
Знайти повний текст джерелаThe war against hepatitis B: A history of the International Task Force on Hepatitis B Immunization. Philadelphia: University of Pennsylvania Press, 1995.
Знайти повний текст джерелаЧастини книг з теми "Hepatitis A Vaccination"
Inchauspé, Geneviève. "Gene vaccination for hepatitis C." In Gene Vaccination: Theory and Practice, 109–19. Berlin, Heidelberg: Springer Berlin Heidelberg, 1998. http://dx.doi.org/10.1007/978-3-642-46867-4_10.
Повний текст джерелаUchida, Toshikazu, Toshio Shikata, Tetsuji Rikihisa, Munetaka Ichikawa, and Kyosuke Mizuno. "Vaccination of Hepatitis E Virus." In Viral Hepatitis and Liver Disease, 547–49. Tokyo: Springer Japan, 1994. http://dx.doi.org/10.1007/978-4-431-68255-4_143.
Повний текст джерелаSmyk, Daniel S., Lazaros I. Sakkas, Yehuda Shoenfeld, and Dimitrios P. Bogdanos. "Hepatitis B Vaccination and Autoimmunity." In Vaccines and Autoimmunity, 147–62. Hoboken, NJ, USA: John Wiley & Sons, Inc, 2015. http://dx.doi.org/10.1002/9781118663721.ch16.
Повний текст джерелаIwarson, S. "Diverging policies for vaccination against hepatitis B." In Chronically Evolving Viral Hepatitis, 142–46. Vienna: Springer Vienna, 1992. http://dx.doi.org/10.1007/978-3-7091-5633-9_31.
Повний текст джерелаDavis, Heather L., and Cynthia L. Brazolot Millan. "DNA-based immunization against hepatitis B virus." In Gene Vaccination: Theory and Practice, 93–107. Berlin, Heidelberg: Springer Berlin Heidelberg, 1998. http://dx.doi.org/10.1007/978-3-642-46867-4_9.
Повний текст джерелаRichter, Darko. "Lip Angioedema Following Hepatitis B Vaccination." In Pediatric Allergy, 297–301. Cham: Springer International Publishing, 2019. http://dx.doi.org/10.1007/978-3-030-18282-3_59.
Повний текст джерелаHoward, Colin R. "Control of Hepatitis B by Vaccination." In Concepts in Viral Pathogenesis III, 322–29. New York, NY: Springer New York, 1989. http://dx.doi.org/10.1007/978-1-4613-8890-6_38.
Повний текст джерелаNeurath, A. R., S. B. H. Kent, N. Strick, and K. Parker. "Vaccination with Synthetic Hepatitis B Virus Peptides." In New Vaccines and Chemotherapy, 107–28. Boston, MA: Springer US, 1988. http://dx.doi.org/10.1007/978-1-4757-9268-3_10.
Повний текст джерелаHong, Seo Jin, Min Hye Ahn, Yong Woo Lee, Sukdeb Pal, Jaiprakash Sangshetti, and Rohidas B. Arote. "Biodegradable Polymeric Nanocarrier-Based Immunotherapy in Hepatitis Vaccination." In Advances in Experimental Medicine and Biology, 303–20. Singapore: Springer Singapore, 2018. http://dx.doi.org/10.1007/978-981-13-0950-2_16.
Повний текст джерелаGesemann, M., S. Schröder, N. Scheiermann, and C. Maurer. "Kinetics of anti-HBs after hepatitis B vaccination: a comparison of two recombinant and one plasma-derived vaccines." In Chronically Evolving Viral Hepatitis, 154–55. Vienna: Springer Vienna, 1992. http://dx.doi.org/10.1007/978-3-7091-5633-9_33.
Повний текст джерелаТези доповідей конференцій з теми "Hepatitis A Vaccination"
Kipiani, E., M. Butsashvili, G. Kamkamidze, and G. Abashidze. "STUDY OF RISK FACTORS AFFECTING HBV VACCINE EFFICIENCY AMONG CHILDREN IN GEORGIA." In International Trends in Science and Technology. RS Global Sp. z O.O., 2020. http://dx.doi.org/10.31435/rsglobal_conf/30122020/7346.
Повний текст джерелаBaraka, Fatiha, Chahrazed Kandouci, Fadela Meflah, Menaouar Rehni, and Baderdine Abdelkrim Kandouci. "P086 Hepatitis B and vaccination." In Occupational Health: Think Globally, Act Locally, EPICOH 2016, September 4–7, 2016, Barcelona, Spain. BMJ Publishing Group Ltd, 2016. http://dx.doi.org/10.1136/oemed-2016-103951.407.
Повний текст джерела"Knowledge, Attitude and Perception of Incomplete Hepatitis B Vaccination Among Staff of University College Hospital, Ibadan." In International Conference on Public Health and Humanitarian Action. International Federation of Medical Students' Associations - Jordan, 2022. http://dx.doi.org/10.56950/rfob4613.
Повний текст джерелаReiter, S., K. Dax, A. Penner, C. Watschinger, A. Zollner, and AR Moschen. "COVID-19 vaccination in patients with autoimmune hepatitis." In 54. Jahrestagung & 31. Fortbildungskurs der Österreichischen Gesellschaft für Gastroenterologie & Hepatologie – ÖGGH (Hybrid Veranstaltung). Georg Thieme Verlag KG, 2021. http://dx.doi.org/10.1055/s-0041-1734309.
Повний текст джерелаannatou, yakoubou, and tchiakpè nicole. "P366 The interest of anti hepatitis B vaccination at birth." In Faculty of Paediatrics of the Royal College of Physicians of Ireland, 9th Europaediatrics Congress, 13–15 June, Dublin, Ireland 2019. BMJ Publishing Group Ltd and Royal College of Paediatrics and Child Health, 2019. http://dx.doi.org/10.1136/archdischild-2019-epa.712.
Повний текст джерелаFIGUEIREDO, RAISSA VELASQUES DE, MARIA LÚCIA LEMOS LOPES, TATIANA FREITAS TOURINHO, MARIA ODETE ESTEVES HILÁRIO, RODRIGO PEREIRA DUQUIA, GILBERTO SCANAGATTA, RAFAEL CORADIN, LUANA RIBEIRO CARLOS, and THIAGO WILLERS. "ASIA SYNDROME IN SLE PATIENT AFTER VACCINATION FOR HEPATITIS B." In 36º Congresso Brasileiro de Reumatologia. São Paulo: Editora Blucher, 2019. http://dx.doi.org/10.5151/sbr2019-001.
Повний текст джерелаCsernalabics, Benedikt, Tobias Boettler, Henrike Salié, Hendrik Luxenburger, Lara Wischer, Kathrarina Zoldan, Laurenz Krimmel, et al. "Immune-mediated Hepatitis associated with SARS-CoV-2 mRNA vaccination." In 38. Jahrestagung der Deutsche Arbeitsgemeinschaft zum Studium der Leber. Georg Thieme Verlag, 2022. http://dx.doi.org/10.1055/s-0041-1740810.
Повний текст джерелаCorrea, Tulio. "P67 Vaccination against hepatitis A and hepatitis B infections in Brazil during the COVID-19 pandemic." In Abstracts of the BSG Annual Meeting, 20–23 June 2022. BMJ Publishing Group Ltd and British Society of Gastroenterology, 2022. http://dx.doi.org/10.1136/gutjnl-2022-bsg.124.
Повний текст джерелаCastro, Ana Rita Motta, Livia Lima, Larissa Bandeira, Selma Gomes, Barbara Lago, Grazielli Rezende, and Gabriela Alves Cesar. "Hepatitis B: changes in epidemiological features of Afrodescendant communities in Central Brazil." In XIII Congresso da Sociedade Brasileira de DST - IX Congresso Brasileiro de AIDS - IV Congresso Latino Americano de IST/HIV/AIDS. Zeppelini Editorial e Comunicação, 2021. http://dx.doi.org/10.5327/dst-2177-8264-202133p142.
Повний текст джерелаKemal, Rahmat Azhari, Huriatul Masdar, Fajri Marindra Siregar, and Dedi Afandi. "Anti-Hepatitis B surface Titer as Indicator in Faculty of Medicine Universitas Riau Hepatitis B Vaccination Program." In The 3rd Green Development International Conference (GDIC 2020). Paris, France: Atlantis Press, 2021. http://dx.doi.org/10.2991/aer.k.210825.073.
Повний текст джерелаЗвіти організацій з теми "Hepatitis A Vaccination"
Wang, Li Fang, Yan Ting Cao, Tegeleqi Bu, Lin Fu, Jun Li Liu, and Jing Zhao. Do We Receive Cytomegalovirus Vaccination Before Solid Organ Transplant: a Meta-Analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, November 2022. http://dx.doi.org/10.37766/inplasy2022.11.0143.
Повний текст джерелаHajarizadeh, Behzad, Jennifer MacLachlan, Benjamin Cowie, and Gregory J. Dore. Population-level interventions to improve the health outcomes of people living with hepatitis B: an Evidence Check brokered by the Sax Institute for the NSW Ministry of Health, 2022. The Sax Institute, August 2022. http://dx.doi.org/10.57022/pxwj3682.
Повний текст джерелаGidengil, Courtney, Matthew Bidwell Goetz, Margaret Maglione, Sydne J. Newberry, Peggy Chen, Kelsey O’Hollaren, Nabeel Qureshi, et al. Safety of Vaccines Used for Routine Immunization in the United States: An Update. Agency for Healthcare Research and Quality (AHRQ), May 2021. http://dx.doi.org/10.23970/ahrqepccer244.
Повний текст джерела